Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Evkeeza for homozygous familial hypercholesterolemia

Feb. 12, 2021

FDA grants EUA for etesevimab and bamlanivimab for mild to moderate COVID-19

Feb. 10, 2021

FDA approves Libtayo for advanced basal cell carcinoma

Feb. 10, 2021

FDA approves Breyanzi for relapsed or refractory large B-cell lymphoma

Feb. 8, 2021

FDA grants accelerated approvals of Ukoniq for marginal zone lymphoma and follicular lymphoma

Feb. 8, 2021

Korean MFDS grants conditional marketing authorization for Regkirona for COVID-19

Feb. 8, 2021

FDA grants accelerated approval to Tepmetko for metastatic NSCLC with METex14 skipping alterations

Feb. 4, 2021

E.U. grants conditional marketing authorization to AstraZeneca COVID-19 vaccine

Feb. 1, 2021

Rinvoq approved in E.U. for psoriatic arthritis and ankylosing spondylitis

Jan. 26, 2021

Hunterase ICV approved in Japan for MPS II

Jan. 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...